Dermatology Times: July 7, 2025

12345678910111213141516
Across
  1. 4. Acronym for gene expression profiling guiding melanoma and SCC management.
  2. 6. Focus of the 2024 Incyte Ingenuity Awards promoting advocacy and innovation.
  3. 8. Type of aesthetic approach favored over quick fixes, per Robin Smith, MD.
  4. 9. Biologic studied in the ADmirable trial for efficacy in skin of color.
  5. 12. (Abbreviation) Skin cancer subtype discussed in GEP-guided treatment strategies.
  6. 13. Ongoing issue among dermatology trainees despite pandemic recovery.
  7. 14. (Abbreviation) Imaging technology enhanced by e-learning for better BCC diagnosis.
  8. 16. Chronic disease examined in recent cost-effectiveness studies.
Down
  1. 1. Castle Biosciences’ trial on cSCC featuring PA involvement in research roles.
  2. 2. Topical treatment showing promise for sensitive skin areas in atopic dermatitis.
  3. 3. Injectable gel under FDA review for use on neck lines.
  4. 5. Aesthetic concern addressed by lebrikizumab in patients with skin of color.
  5. 7. Dermatologist featured in a Q&A on biologics and patients with skin of color.
  6. 10. Tiny vesicles powering regenerative aesthetics in Robin Smith, MD’s Exoceuticals brand.
  7. 11. Alphyn Biologics' hydrogel that targets inflammation, itch, and bacteria in AD.
  8. 15. (Abbreviation) Submission type filed to expand aesthetic injectable's indication to neck treatment.